Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

NASH Screening in Diabetes

Source: Hot Topics in NASH: Current Controversies and New Developments in Fatty Liver Disease
Hear Brent A. Neuschwander-Tetri, MD, explore NASH screening and the interplay among NAFLD, metabolic syndrome, CV risk, and diabetes risk.
Brent A. Neuschwander-Tetri, MD
Released: July 7, 2020

Hear Brent A. Neuschwander-Tetri, MD, explore NASH screening and the interplay among NAFLD, metabolic syndrome, CV risk, and diabetes risk, including:

  • Should We Screen for NASH?
    • Role of obesity and type 2 diabetes mellitus
  • Cardiovascular Risk in NAFLD/NASH
  • How to Evaluate for NAFLD/NASH
    • Biomarkers
    • Imaging
    • When/whom to biopsy?
  • Management in Multidisciplinary Settings

Download the slides from this podcast at: https://www.clinicaloptions.com/internal-medicine/programs/2019-nash-hot-topics/screening-for-nash-in-patients-with-diabetes/slideset

See more NASH topics at: https://www.clinicaloptions.com/internal-medicine/programs/2019-nash-hot-topics

Acknowledgements

Provided by the American Gastroenterology Association.
Contact Info

American Gastroenterological Association (AGA)
4930 Del Ray Avenue
Bethesda, MD 20814
Phone: (301) 654-2055
Fax: (301) 654-5920
Email: member@gastro.org

Produced in collaboration with
Endocrine Society Logo
Supported by educational grants from
Allergan
Gilead Sciences
Intercept Pharmaceuticals, Inc.

Related Content

From CCO: Susan Schrimpf Davis, DO; Cynthia J. Gerstenlauer, ANP-BC, GCNS-BC, CDE, CCD; Deborah A. Milito, PharmD, BCGP, FASCP, discuss the importance of vaccinating older adults against shingles and how to overcome common clinical challenges

Susan Schrimpf Davis, DO Cynthia J. Gerstenlauer, ANP-BC, GCNS-BC, CDE, CCD Deborah A. Milito, PharmD, BCGP, FASCP Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: October 22, 2020 Expired: October 21, 2021

Susan Schrimpf Davis, DO Released: October 7, 2020

Expert commentary on hATTR pathobiology and the importance of early and accurate diagnosis.

Aaron Walfish, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Released: October 1, 2020 Expired: September 30, 2021

Short CME/CE-certified video from CCO: Expert review of case studies improving evaluation and diagnosis of patients with hATTR.

Jonathan Mazurek, MD Aaron Walfish, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Released: September 21, 2020 Expired: September 20, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue